Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tuberculosis Treatment Monitoring and Outcome Measures: New Interest and New Strategies
Jan Heyckendorf, Sophia B. Georghiou, Nicole Frahm, et al.
Clinical Microbiology Reviews (2022) Vol. 35, Iss. 3
Open Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

Update on the diagnosis of tuberculosis
Irina Kontsevaya, Andrea Maurizio Cabibbe, Daniela María Cirillo, et al.
Clinical Microbiology and Infection (2023) Vol. 30, Iss. 9, pp. 1115-1122
Open Access | Times Cited: 42
Recent advances in the treatment of tuberculosis
Ilaria Motta, Martin J. Boeree, Dumitru Chesov, et al.
Clinical Microbiology and Infection (2023) Vol. 30, Iss. 9, pp. 1107-1114
Open Access | Times Cited: 34
The TB27 Transcriptomic Model for Predicting Mycobacterium tuberculosis Culture Conversion
Maja Reimann, Korkut Avsar, Andrew R. DiNardo, et al.
Pathogens and Immunity (2025) Vol. 10, Iss. 1, pp. 120-139
Open Access | Times Cited: 1
Current state-of-the-art and gaps in platform trials: 10 things you should know, insights from EU-PEARL
Franz Koenig, Cécile Spiertz, Daniel Millar, et al.
EClinicalMedicine (2023) Vol. 67, pp. 102384-102384
Open Access | Times Cited: 17
A deep insight into ferroptosis in lung disease: facts and perspectives
Fan Zhang, Xiang Yu, Qiao Ma, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 6
A CRISPR-Cas12a-based platform for ultrasensitive rapid highly specific detection of Mycobacterium tuberculosis in clinical application
Nan Jia, Chao-hong Wang, Xiaming Liu, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 15
Pharmacokinetics and pharmacodynamics of anti-tuberculosis drugs: An evaluation of in vitro, in vivo methodologies and human studies
Jan‐Willem C. Alffenaar, Jurriaan E.M. de Steenwinkel, Andreas H. Diacon, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 21
New Insights into Biomarkers for Evaluating Therapy Efficacy in Pulmonary Tuberculosis: A Narrative Review
Fuzhen Zhang, Fan Zhang, Yu Dong, et al.
Infectious Diseases and Therapy (2023) Vol. 12, Iss. 12, pp. 2665-2689
Open Access | Times Cited: 11
Target product profiles: tests for tuberculosis treatment monitoring and optimization
Ankur Gupta‐Wright, Saskia den Boon, Emily MacLean, et al.
Bulletin of the World Health Organization (2023) Vol. 101, Iss. 11, pp. 730-737
Open Access | Times Cited: 11
Assessing the effects of diabetes mellitus on the monocyte-to-lymphocyte ratio and the QuantiFERON-TB gold plus assays for tuberculosis treatment monitoring: a prospective cohort study
Paulo Ranaivomanana, Arimanitra Razafimahefa, Mame Diarra Ndiaye, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Tuberculosis Diagnosis and Management: Recent Advances
Arti Shrivas, Sarman Singh
Journal of Global Infectious Diseases (2025) Vol. 17, Iss. 1, pp. 3-9
Open Access
Integrated Public-Private Partnerships to Combat Tuberculosis for Improving Economic Development
S. Srinivasan, R. Vallipriya, Ajay Kumar Singh
IGI Global eBooks (2025), pp. 323-356
Closed Access
Host Response Biomarkers of Tuberculosis Recurrence and Treatment Failure
Bernadette Bauer, Mohamed I. M. Ahmed, Olga Baranov, et al.
(2025)
Closed Access
Innovative electrochemical biosensors for tuberculosis detection
Mahdi Sadeghi, Safa Radmehr, Neda Mohagheghzadeh, et al.
Clinica Chimica Acta (2025) Vol. 574, pp. 120327-120327
Closed Access
Tuberculosis treatment monitoring tests during routine practice: study design guidance
Emily MacLean, Alexandra J. Zimmer, Saskia den Boon, et al.
Clinical Microbiology and Infection (2024) Vol. 30, Iss. 4, pp. 481-488
Open Access | Times Cited: 3
Neutrophil lncRNA ZNF100-6:2 is a potential diagnostic marker for active pulmonary tuberculosis
Shuying Huang, Xiuhua Kang, Zhenguo Zeng, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 3
The plasma kynurenine-to-tryptophan ratio as a biomarker of tuberculosis disease in people living with HIV on antiretroviral therapy: an exploratory nested case–control study
Sivaporn Gatechompol, René Lutter, Frédéric M. Vaz, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Metagenomic next-generation sequencing for Mycobacterium tuberculosis complex detection: a meta-analysis
Yulian Li, Wentao Bian, Shiping Wu, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 9
Spotlight on mycobacterial lipid exploitation using nanotechnology for diagnosis, vaccines, and treatments
Carlos M. Valdemar-Aguilar, Ravichandran Manisekaran, Laura Susana Acosta‐Torres, et al.
Nanomedicine Nanotechnology Biology and Medicine (2023) Vol. 48, pp. 102653-102653
Open Access | Times Cited: 7
circRNA_SLC8A1 promotes the survival of mycobacterium tuberculosis in macrophages by upregulating expression of autophagy-related protein SQSTM1/p62 to activate the NF-κB pathway
Zhenyun Li, Yuan Gao, Zhang Bian-fang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Kynurenines as a Novel Target for the Treatment of Inflammatory Disorders
Adrian Mor, Anna Tankiewicz‐Kwedlo, Marianna Ciwun, et al.
Cells (2024) Vol. 13, Iss. 15, pp. 1259-1259
Open Access | Times Cited: 2
Detecting latent tuberculosis infection with a breath test using mass spectrometer: A pilot cross-sectional study
Liang Fu, Yong Feng, Tantan Ren, et al.
BioScience Trends (2023) Vol. 17, Iss. 1, pp. 73-77
Open Access | Times Cited: 6
Bottlenecks and recent advancements in detecting Mycobacterium tuberculosis in patients with HIV
Zixun Lin, Liqin Sun, Cheng Wang, et al.
iLABMED (2023) Vol. 1, Iss. 1, pp. 44-57
Open Access | Times Cited: 5
Diagnostic efficacy of an optimized nucleotide MALDI-TOF–MS assay for anti-tuberculosis drug resistance detection
Xichao Ou, Zexuan Song, Bing Zhao, et al.
European Journal of Clinical Microbiology & Infectious Diseases (2023) Vol. 43, Iss. 1, pp. 105-114
Closed Access | Times Cited: 5
Large-scale analysis reveals splicing biomarkers for tuberculosis progression and prognosis
Hongli Lai, Mengyuan Lyu, Hongxia Ruan, et al.
Computers in Biology and Medicine (2024) Vol. 171, pp. 108187-108187
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top